<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04144946</url>
  </required_header>
  <id_info>
    <org_study_id>BBH-148</org_study_id>
    <nct_id>NCT04144946</nct_id>
  </id_info>
  <brief_title>Identification of Early Changes in Patellar Tendinopathy Using Ultra-high Field Strength MRI</brief_title>
  <acronym>7TKnee</acronym>
  <official_title>Identification of Early Changes in Patellar Tendinopathy Using Ultra-high Field Strength MRI</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project will investigate patellar tendon tissue (transmission electron microscopy of&#xD;
      structure and protein analyses) coupled with magnetic resonance imaging (1.5T and 7T) from&#xD;
      persons with i) chronic patellar tendinopathy (CT), ii) the earliest possible signs and&#xD;
      symptoms of patellar tendinopathy (ET), and iii) symptom free controls (CTRL)(matched for age&#xD;
      and physical activity/sports participation).&#xD;
&#xD;
      The investigators hypothesize that 7T MRI will be able to detect more subtle changes in early&#xD;
      tendinopathy as compared to 3T MRI, thereby taking advantage of the increased spatial&#xD;
      resolution that can be obtained in MRI with higher field strength. Further the investigator&#xD;
      hypothesise that alterations in the tissue will be more pronounced in the CT group compared&#xD;
      to ET and healthy controls.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Tendon tissue plays an essential role in transmitting contractile forces to bone to produce&#xD;
      movement and is therefore uniquely designed to withstand considerable loads (up to ~8 times&#xD;
      body weight) during human locomotion. Yet, repetitive use often results in overuse injuries&#xD;
      such as tendinopathies, which is a common clinical condition characterized by pain during&#xD;
      activity, localized tenderness upon palpation, swelling of the tendon and impaired&#xD;
      performance. Tendinopathy is a sizeable problem in both elite and recreational athletes. In&#xD;
      fact, the incidence of tendon injuries has been estimated to be as high as 30-50% of all&#xD;
      sports injuries, and 50% of elite endurance runners, and 6% of sedentary people will at some&#xD;
      point experience a tendon injury. Moreover, the symptoms and reduction in performance may be&#xD;
      quite protracted and last for years. To date the ability to detect the early onset of the&#xD;
      disease, and thus to prevent it from becoming chronic and debilitating, remains an enigma and&#xD;
      the investigators wish to bridge this gap in knowledge by studying patellar tendon tissue&#xD;
      samples coupled with magnetic resonance imaging (3T and 7T)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 18, 2019</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cross sectional area (CSA) on Magnetic Resonance Imaging knee scans</measure>
    <time_frame>0 months, observational cross sectional study.</time_frame>
    <description>Magnetic Resonance Imaging of the knee, used to measure cross sectional area (cm^2)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Decay times from Magnetic Resonance Imaging knee scans</measure>
    <time_frame>0 months, observational cross sectional study.</time_frame>
    <description>Magnetic Resonance Imaging of the knee used to calculate decay times (ms) in the tendon tissue.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Patellar tendon biopsies</measure>
    <time_frame>0 months, observational cross sectional study.</time_frame>
    <description>Tendon biopsies obtained with bard magnum instrument approximately 10 mg. Used for quantitative mRNA measures expressed as relative values to the expression of a housekeeping gene with stable expression (AU).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>International Physical Activity Questionnaire (IPAQ)</measure>
    <time_frame>0 months, observational cros sectional study.</time_frame>
    <description>IPAQ categorical scores (High, moderate or low activity level) will be reported, to characterise participants activity level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Mass Index</measure>
    <time_frame>0 months, observational cross sectional study.</time_frame>
    <description>BMI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaires - weekly activity level (time consumption)</measure>
    <time_frame>0 months, observational cross sectional study.</time_frame>
    <description>hours/week spend on leisure time activities loading the legs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaires - Numerical Rating Scale (NRS) - Pain</measure>
    <time_frame>0 months, observational cross sectional study.</time_frame>
    <description>range 0-10, 10 being the highest possible pain level and 0 being no pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VISA-P</measure>
    <time_frame>0 months, observational cross sectional study.</time_frame>
    <description>Standardised score of functional capability, in patient with patellar tendinopathy. Total score will be reported; scale (0-100). 100=full functional capacity 0=poor functional capacity.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Tendon Injuries</condition>
  <condition>Tendinopathy</condition>
  <condition>Patella; Tendinitis</condition>
  <arm_group>
    <arm_group_label>Healthy control group (CTRL)</arm_group_label>
    <description>Sports active individuals with no history of patellar tendinopathy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Early tendinopathy group (ET)</arm_group_label>
    <description>Sports active individuals with clinical signs of early tendinopathy and debut of symptoms within 90 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chronic tendinopathy group (CT)</arm_group_label>
    <description>Sports active individuals with clinical signs of tendinopathy and duration of symptoms &gt;90 days.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Bilateral tendon biopsies&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Sports active individuals&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Common for all groups&#xD;
&#xD;
          -  Sports active individuals.&#xD;
&#xD;
          -  Age [18-45] years old.&#xD;
&#xD;
          -  BMI [18.5-30]&#xD;
&#xD;
        ET - group&#xD;
&#xD;
          -  Symptom onset within 90 days at inclusion&#xD;
&#xD;
          -  Clinical signs of patellar tendinopathy.&#xD;
&#xD;
          -  Activity related pain in the patellar tendon.&#xD;
&#xD;
          -  Palpation pain in the proximal part of the patellar tendon.&#xD;
&#xD;
          -  At least one of the following three changes on the ultrasound scanning:&#xD;
&#xD;
               -  Thickening of the AP diameter on the symptomatic side.&#xD;
&#xD;
               -  Increased Power Doppler signal on the symptomatic side.&#xD;
&#xD;
               -  Hypoechogenic area corresponding to the symptomatic area of the tendon.&#xD;
&#xD;
        CT - group,&#xD;
&#xD;
          -  Symptom onset &gt;90 days ago&#xD;
&#xD;
          -  Clinical signs of patellar tendinopathy.&#xD;
&#xD;
          -  Activity related pain in the patellar tendon.&#xD;
&#xD;
          -  Palpation pain in the proximal part of the patellar tendon.&#xD;
&#xD;
          -  At least one of the following three changes on the ultrasound scanning:&#xD;
&#xD;
               -  Thickening of the AP diameter on the symptomatic side.&#xD;
&#xD;
               -  Increased Power Doppler signal on the symptomatic side.&#xD;
&#xD;
               -  Hypoechogenic area corresponding to the symptomatic area of the tendon.&#xD;
&#xD;
        CTRL - group - Similar activity level as the two patient groups.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Common for all groups&#xD;
&#xD;
          -  Previous surgery in the knee on the ipsilateral side.&#xD;
&#xD;
          -  Previous corticosteroid injection in the patellar tendon on the ipsilateral side.&#xD;
&#xD;
          -  Smoking&#xD;
&#xD;
          -  Known arthritis&#xD;
&#xD;
          -  Known diabetes&#xD;
&#xD;
          -  Known hypercholesterolemia&#xD;
&#xD;
          -  Previous injections in the ipsilateral tendon.&#xD;
&#xD;
          -  MRI contraindications&#xD;
&#xD;
               -  Ferromagnetic objects&#xD;
&#xD;
               -  Pregnancy&#xD;
&#xD;
               -  Lactation&#xD;
&#xD;
        ET - group&#xD;
&#xD;
          -  Previous injuries in the patellar tendon on the ipsilateral side.&#xD;
&#xD;
          -  Started systematized treatment.&#xD;
&#xD;
        CTRL - group&#xD;
&#xD;
        - Previous injuries in the patellar tendon on the ipsilateral side.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Kjær, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Sports Medicine, Copenhagen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nikolaj Malmgaard-Clausen, MD</last_name>
    <phone>+4538635069</phone>
    <email>nikolaj.moelkjaer.malmgaard-clausen@regionh.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Institute of Sports Medicine Copenhagen</name>
      <address>
        <city>Copenhagen</city>
        <state>NV</state>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nikolaj M. Malmgaard-Clausen, MD</last_name>
      <phone>+4538635069</phone>
      <email>nmal0015@regionh.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>October 18, 2019</study_first_submitted>
  <study_first_submitted_qc>October 29, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2019</study_first_posted>
  <last_update_submitted>March 23, 2021</last_update_submitted>
  <last_update_submitted_qc>March 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bispebjerg Hospital</investigator_affiliation>
    <investigator_full_name>Nikolaj Mølkjær Malmgaard-Clausen</investigator_full_name>
    <investigator_title>Medical Doctor, PhD student</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tendinopathy</mesh_term>
    <mesh_term>Tendon Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

